CP-88,8 18 (p-tigogenin cellobioside) is a novel hypochobsterolemic and anti-atherosclerosis agent which acts by inhibiting the absorption of dietary and biliary cholesterol. While the exact mechanism of this inhibition is unclear, CP-88,818 is believed to block cholesterol absorption without entering the body. In order to prove this hypothesis, radiolabelled CP-88,818 was needed. Herein, we report the stereoselective synthesis of [5,6-3H2]CP-88.818 in four steps from diosgenin acetate.
DISCUSSIONCatalytic reduction of diosgenin could provide two diastereomers, smilagenin arid tigogenin.Literature5 in this area suggested reducing a diosgenin derivative with the 3-hydroxyl group protected in order to avoid this functional group directing reduction to the p-face. With direct literature precedence lacking, however, we decided to investigate the stereochemical course of this reduction